CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

NEXT STORY
Kinross reports 2019 fourth-quarter and full-year results
PREV STORY
Ascendis Pharma A/S Announces Upcoming Investor Presentation in February
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ICU Beds Global Market Report 2021: COVID-19 Implications And Growth To 2030

author_avatar
NASDAQ Market News

Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance

author_avatar
NASDAQ Market News

Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

author_avatar
NASDAQ Market News